Localized leishmaniasis treated with intralesional meglumine antimoniate

03 medical and health sciences Meglumine Antimoniate Treatment Outcome 0302 clinical medicine Antiprotozoal Agents Humans Leishmaniasis, Cutaneous Injections, Intralesional
DOI: 10.1111/ddg.14165 Publication Date: 2020-07-13T05:44:04Z
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....